Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-20

Clinical Trial Update: Evaluation of ATx201 as a Topical Antibiotic Agent [Phase 1, Phase 2]

View source ↗

Summary

The document reports completion of a Phase 1/2 study evaluating ATx201 as a topical antibiotic for bacterial infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATx201

Snippet

Sponsor: UNION therapeutics | Conditions: Infection, Bacterial | Phase 1, Phase 2 | Status: COMPLETED